<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20436" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Diabetic Amyotrophy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Diaz</surname>
            <given-names>Levi A.</given-names>
          </name>
          <aff>Mount Sinai Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Levi Diaz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20436.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Diabetic amyotrophy, better known as diabetic lumbosacral radiculoplexus neuropathy (DLRPN), is a rare disorder englobed in the diabetic neuropathy spectrum. This disease consists of a monophasic, asymmetrical progression of pain, motor weakness, proximal muscle atrophy, weight loss, areflexia, progression to paraplegia, and recent diagnosis of diabetes. Diagnosis is mostly based on clinically suggestive findings in a recently diagnosed patient with diabetes. In cases were other likely etiologies need to be excluded, laboratory analysis (e.g., CBC, CMP, HbA1C, ESR, CRP, etc.) and other diagnostic studies may be warranted (CT, MRI, EMG, biopsy, etc.). Early use of immunomodulators (e.g., steroids, IVIG, etc.) has been proposed as a superior therapy, but symptomatic treatment to improve quality of life may suffice, as this disease is self-limited in most cases, with a variable degree of impairment. This activity describes the recognition, evaluation, and management of diabetic amyotrophy and highlights the role of the healthcare team in evaluating, identifying, and improving patient care for this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of diabetic amyotrophy.</p></list-item><list-item><p>Outline the typical presentation of a patient with diabetic amyotrophy.</p></list-item><list-item><p>Summarize the various management options available for diabetic amyotrophy.</p></list-item><list-item><p>Explain the importance of improving care coordination amongst the interprofessional team to enhance the delivery of care for patients with diabetic amyotrophy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20436&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20436">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20436.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Diabetic lumbosacral radiculoplexus neuropathy (DLRPN), also known as diabetic amyotrophy, Bruns-Garland syndrome, proximal diabetic neuropathy, diabetic polyradiculopathy, multifocal diabetic neuropathy, femoral-sciatic neuropathy of diabetes, diabetic myelopathy, diabetic motor neuropathy, diabetic mononeuritis multiplex, and paralytic neuropathy classifies as part of the diabetic neuropathy spectrum. The various terms that allude to this disorder constitute evidence of the contrasting viewpoints regarding the anatomical localization and underlying pathophysiology&#x000a0;of this disorder.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r2">[2]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r5">[5]</xref><xref ref-type="bibr" rid="article-20436.r6">[6]</xref></p>
        <p>Initial recognition of this condition, dates back to the late 19th century,&#x000a0;as Leyden first described it in 1877 and Auche in 1890, but the original description of DLRPN is attributed to Bruns in 1890 by most authors.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><bold>&#x000a0;</bold>It was not until the 1950s when Hugh Garland brought into being the term &#x0201c;diabetic amyotrophy.&#x0201d;&#x000a0;In his research, he described the clinical course of 12 patients with&#x000a0;asymmetrical, progressing, diffuse lower extremity pain, motor-weakness, accompanied with muscle wasting, weight loss, and areflexia, with a clear relation to uncontrolled diabetes and close to complete recovery with appropriate glycemic management.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r5">[5]</xref></p>
        <p>The anatomical and pathophysiologic mechanism of diabetic amyotrophy is not completely understood, but there is evidence of injury to the peripheral nerves, nerve roots, lumbosacral plexus, with accompanying axonal degeneration, demyelination, inflammation, ischemia, and immune-mediated microvasculitis.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r6">[6]</xref><xref ref-type="bibr" rid="article-20436.r7">[7]</xref><xref ref-type="bibr" rid="article-20436.r8">[8]</xref><xref ref-type="bibr" rid="article-20436.r9">[9]</xref><xref ref-type="bibr" rid="article-20436.r10">[10]</xref></p>
      </sec>
      <sec id="article-20436.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There is increasing evidence for an inflammatory-immune mediated microvasculitis, with clear association to diabetes, but an unclear link in its pathophysiology.<xref ref-type="bibr" rid="article-20436.r6">[6]</xref><xref ref-type="bibr" rid="article-20436.r8">[8]</xref><xref ref-type="bibr" rid="article-20436.r11">[11]</xref></p>
        <p>Risk factors for DLRPN include <xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r6">[6]</xref><xref ref-type="bibr" rid="article-20436.r8">[8]</xref><xref ref-type="bibr" rid="article-20436.r6">[6]</xref>:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>More commonly affecting patients with type 2 diabetes mellitus <xref ref-type="bibr" rid="article-20436.r6">[6]</xref><xref ref-type="bibr" rid="article-20436.r8">[8]</xref>:</p>
          </list-item>
          <list-item>
            <p>Rapid glycemic management&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Tight glycemic management&#x000a0;</p>
          </list-item>
        </list>
        <p>Other possible risk factors include <xref ref-type="bibr" rid="article-20436.r3">[3]</xref>:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Starting hyperglycemic treatment</p>
          </list-item>
          <list-item>
            <p>Immunizations</p>
          </list-item>
          <list-item>
            <p>Trauma</p>
          </list-item>
          <list-item>
            <p>Infections&#x000a0;</p>
          </list-item>
        </list>
        <p>As part of the lumbosacral plexopathies, there is a wide etiological array including <xref ref-type="bibr" rid="article-20436.r6">[6]</xref>:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Diabetic lumbosacral radiculoplexus neuropathy (DLRNP - diabetic amyotrophy)</p>
          </list-item>
          <list-item>
            <p>Idiopathic lumbosacral radiculoplexus neuropathy (DLRNP)</p>
          </list-item>
          <list-item>
            <p>Inflammatory/microvasculitis</p>
          </list-item>
          <list-item>
            <p>Trauma</p>
          </list-item>
          <list-item>
            <p>Retroperitoneal hematoma</p>
          </list-item>
          <list-item>
            <p>Neoplasms/metastasis</p>
          </list-item>
          <list-item>
            <p>Dural arteriovenous&#x000a0;fistulas&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Infection</p>
          </list-item>
          <list-item>
            <p>Radiation</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20436.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>DLRPN is a rare presentation of diabetic neuropathy, occurring in approximately 1% of all diabetic patients. This disorder is more frequently seen in males and type II diabetic patients, as compared to type I.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r8">[8]</xref><xref ref-type="bibr" rid="article-20436.r11">[11]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref>&#x000a0;This syndrome affects an older diabetic group, usually over 50 years,&#x000a0;but the median age of onset is over 65 years.<xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r5">[5]</xref><xref ref-type="bibr" rid="article-20436.r11">[11]</xref></p>
        <p>The median period from the initial diagnosis of diabetes, to the&#x000a0;onset of DLRPN, is estimated to be approximately 4.1 years.<xref ref-type="bibr" rid="article-20436.r11">[11]</xref></p>
        <p>A population sample studied at Olmsted County, MN, estimated the incidence of LRPN at approximately 4.16 per 100,000 per year, while the estimated incidence of DLRPN was approximately 2.79 per 100,000 per year. This data may differ from the general US population, as a less ethnically diverse population was studied.<xref ref-type="bibr" rid="article-20436.r6">[6]</xref></p>
      </sec>
      <sec id="article-20436.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Diabetic Amyotrophy or DLRPN is an episodic, monophasic, asymmetrical neuropathy, with acute to subacute onset. The belief is that it is due to an immune-mediated, inflammatory state, resulting in vasculitis with ischemic nerve injury. This disorder may last from a few months, and up to 2 years.&#x000a0;Although comparable to other neuropathies seen with diabetes, this disease is associated with less prolonged exposure to hyperglycemia, better glycemic control, tight glucose management, less diabetic micro/macrovascular complication (i.e., retinopathy, cardiovascular disease, etc.) development and a lower body mass index (BMI) than the average diabetic population. This information suggests a less&#x000a0;clear association between diabetes, DLRPN, and disease severity.</p>
        <p>Due to these findings and the negligible association between DLPRN and pre-diabetes, it may be theorized, that diabetes is a risk factor for this disease and not its primary cause. Abnormal sphingolipid metabolism has demonstrated a critical regulatory role in immunity and&#x000a0;inflammation, which could also play a role in the&#x000a0;pathogenic mechanism of injury.<xref ref-type="bibr" rid="article-20436.r13">[13]</xref>&#x000a0;Furthermore, there are striking pathophysiologic similarities between DLRPN and LRPN (idiopathic lumbosacral radiculoplexus neuropathy), suggesting they may be the same disease process. More studies are necessary to fully understand the mechanism of injury and the true role of diabetes in this disease.<xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r8">[8]</xref><xref ref-type="bibr" rid="article-20436.r9">[9]</xref><xref ref-type="bibr" rid="article-20436.r10">[10]</xref>&#x000a0;</p>
        <p>Nerve biopsy evaluation has demonstrated degenerative changes secondary to microvasculitis with accompanying ischemia and inflammation, further ratified by CSF findings demonstrating elevated protein. These different degenerative changes due to inflammation and ischemia are presumed to be triggered by an immune response, possibly secondary to diabetes.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r2">[2]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r10">[10]</xref></p>
        <p>Neurophysiology studies (i.e., nerve conduction studies, electromyographic examination) have demonstrated a multifocal process involving: the lumbosacral plexus, nerve roots, and the peripheral nerves (peripheral denervation changes).<xref ref-type="bibr" rid="article-20436.r10">[10]</xref>&#x000a0;Pathophysiologic similarities have been described between DLRPN, diabetic cervical radiculoplexus neuropathy (DCRPN), and diabetic thoracic radiculoplexus neuropathy (DTRPN). Similar pathophysiologic findings, as well as frequent comorbid occurrence, signal a common underlying mechanism and are the reason why these&#x000a0;three entities may classify under the same spectrum of disease: diabetic radiculoplexus neuropathy.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r6">[6]</xref><xref ref-type="bibr" rid="article-20436.r7">[7]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r9">[9]</xref><xref ref-type="bibr" rid="article-20436.r10">[10]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref><xref ref-type="bibr" rid="article-20436.r14">[14]</xref></p>
      </sec>
      <sec id="article-20436.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Nerve biopsy is not essential for the diagnosis of DLRPN, but cutaneous (sural and/or superficial peroneal) nerve biopsies have undergone analysis utilizing different histochemical stains, which have served for a better understanding of the disease process. As seen with ischemic injury, reports of asymmetrical, multifocal degeneration, loss of fibers within the nerve fascicles, perineurium fibrosis, neovascularization, and hemosiderin build-up have been recorded. Lastly, epineurial microvessel inflammatory infiltrates (mural and perivascular infiltration), vessel wall necrosis, separation of the smooth muscle layer of vessels, and bleeding (hemosiderin-laden macrophages) have also been evidenced.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r2">[2]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r5">[5]</xref><xref ref-type="bibr" rid="article-20436.r6">[6]</xref><xref ref-type="bibr" rid="article-20436.r7">[7]</xref><xref ref-type="bibr" rid="article-20436.r8">[8]</xref><xref ref-type="bibr" rid="article-20436.r10">[10]</xref></p>
      </sec>
      <sec id="article-20436.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Typically presenting in the elderly (median age 65 years), DLRPN is an episodic, monophasic disease that is clinically active for a relatively short period (few months - 2 years). This neuropathy presents acutely/subacutely, with an asymmetrical, focalized, unilateral, and proximal lower extremity (thigh, buttocks, or hip) distribution early in the disease. Widespread, multifocal, bilateral progression becomes apparent as disease advances, with a wide range of symptomatic severity.&#x000a0;</p>
        <p>Presentations include severe neuropathic pain (most aggravating initial symptom), with predominant motor-strength weakness, proximal muscle atrophy, and frequently associated weight loss (typically exceeding 10 lbs). Progressive worsening of the disease process is seen, until eventual stabilization, and gradual recovery, often with some degree of impairment.&#x000a0;In comparison to other complications caused by diabetes, patients who present with diabetic amyotrophy, often have newly diagnosed diabetes, a short period of exposure to hyperglycemia, better glycemic control, less diabetic micro/macrovascular complications (i.e., retinopathy, CV disease, etc.), and a lower BMI than the average diabetic population.<xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r5">[5]</xref><xref ref-type="bibr" rid="article-20436.r6">[6]</xref><xref ref-type="bibr" rid="article-20436.r7">[7]</xref><xref ref-type="bibr" rid="article-20436.r8">[8]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref><xref ref-type="bibr" rid="article-20436.r14">[14]</xref></p>
        <p>Other findings include<xref ref-type="bibr" rid="article-20436.r8">[8]</xref>:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Numbness</p>
          </list-item>
          <list-item>
            <p>Tingling</p>
          </list-item>
          <list-item>
            <p>Areflexia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Para/quadriplegia</p>
          </list-item>
          <list-item>
            <p>Change in sweating&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Foot drop (long-term complication)</p>
          </list-item>
          <list-item>
            <p>Orthostatic hypotension</p>
          </list-item>
          <list-item>
            <p>Diarrhea</p>
          </list-item>
          <list-item>
            <p>Constipation</p>
          </list-item>
          <list-item>
            <p>Change in sweating</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20436.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Recognition of this syndrome may be challenging since its presentation may have&#x000a0;similar findings as other more worrisome diagnoses. It is a clinical diagnosis, and no definitive test yet exists. Health professionals need to be aware and have a clinical suspicion based on characteristic features in a newly diagnosed diabetic patient to make an adequate diagnosis and avoiding unnecessary testing and procedures.<xref ref-type="bibr" rid="article-20436.r4">[4]</xref>&#x000a0;</p>
        <p>Laboratory/blood investigations may include blood chemistry (electrolytes, liver function tests), hemoglobin A1C level, inflammatory markers (erythrocyte sedimentation rate, C reactive protein), etc.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r5">[5]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref></p>
        <p>CSF evaluation has demonstrated&#x000a0;elevated&#x000a0;protein levels and pleocytosis, suggesting inflammation.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref></p>
        <p>Electrophysiologic testing:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Nerve conduction study: Asymmetrically reduced sensory and motor action potential amplitude in affected muscle sites.<xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref><xref ref-type="bibr" rid="article-20436.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Electromyography (EMG) has shown wide-spread (sensory, motor, autonomic nerves) patchy involvement, fibrillation potentials, prolonged-duration, and high-amplitude motor unit potentials.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref><xref ref-type="bibr" rid="article-20436.r14">[14]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>MRI most commonly is seen with a T2 signal increase, with varying severity.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref><xref ref-type="bibr" rid="article-20436.r14">[14]</xref></p>
        <p>Sural nerve biopsy has been described extensively, to aid for the diagnosis of DLSRP but is not integral in the diagnosis of this syndrome.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref><xref ref-type="bibr" rid="article-20436.r14">[14]</xref></p>
        <p>Laboratory studies, electrophysiologic studies, biopsies, and imaging (X-ray, CT, MRI suspecting compression) may be useful for exclusion of other etiological causes of neurologic symptoms, but emphasis must focus on DLRPN being primarily a clinically based diagnosis.<xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r14">[14]</xref></p>
      </sec>
      <sec id="article-20436.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Diabetic lumbosacral radiculoplexus neuropathy follows a limited disease course. Multiple small studies have correlated improvement of patient outcomes regarding symptomatic improvement with the use of immunosuppressant agents: steroids, immunoglobulin, and plasma exchange, but clear evidence is still necessary due to conflicting outcomes.<xref ref-type="bibr" rid="article-20436.r4">[4]</xref></p>
        <p>In a double blinded-study, including 75 patients, comparing high-dose steroid (weekly dose of 1g methylprednisolone, for 12 weeks) vs. placebo, there was a statistically significant improvement in the patient&#x02019;s secondary end-point (symptomatic improvement&#x000a0;of pain and weakness). The primary outcome, which measured time to improvement, was not met, as it demonstrated both patient samples had improvement in subsequent evaluations. The hypothesis is that earlier intervention in patients using steroids would result in a more favorable outcome than patients not using steroids. Ultimately, no conclusive evidence has shown support for the use of immunomodulators.<xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r7">[7]</xref><xref ref-type="bibr" rid="article-20436.r8">[8]</xref><xref ref-type="bibr" rid="article-20436.r9">[9]</xref><xref ref-type="bibr" rid="article-20436.r11">[11]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref><xref ref-type="bibr" rid="article-20436.r15">[15]</xref><xref ref-type="bibr" rid="article-20436.r16">[16]</xref></p>
        <p>The treatment itself is centered mainly on symptomatic management of pain, management of hyperglycemia, and improvement in mobility. Pain management with paracetamol and NSAIDS is an option. Amitriptyline at night (particularly in accompanying insomnia), selective serotonin receptor inhibitors (SSRIs) for depression/anxiety and anticonvulsant agents are also possibilities. Opiates (tramadol, oxycodone) or steroids may merit consideration&#x000a0;in severe disease, and hospitalization or pain management consultation may also be contemplated in cases with unremitting pain.<xref ref-type="bibr" rid="article-20436.r9">[9]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref>&#x000a0;</p>
        <p>In some cases, when total pain relief is not possible, the goal becomes to make the pain more tolerable for the patient. Appropriate counseling should be given regarding the prolonged course of the disease, providing encouragement due to potential disability and reassurance on some degree of improvement. Disability and home safety, among other problems, should also receive attention. Management of diabetes may be recommended.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref></p>
      </sec>
      <sec id="article-20436.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Diabetic neuropathy</p>
          </list-item>
          <list-item>
            <p>Nerve root compression&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Diabetic muscle infarction&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Infiltrative pelvic malignancy</p>
          </list-item>
          <list-item>
            <p>Chronic inflammatory demyelinating polyradiculoneuropathy</p>
          </list-item>
          <list-item>
            <p>Vasculitides</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Infections (HIV, Epstein-Barr virus, <italic toggle="yes">Cytomegalovirus</italic>, varicella-zoster virus, syphilis)</p>
          </list-item>
          <list-item>
            <p>Post-radiotherapy, postoperative and obstetric instrumentation.<xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r6">[6]</xref><xref ref-type="bibr" rid="article-20436.r12">[12]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20436.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Overall, a good prognosis is expected&#x000a0;for diabetic amyotrophy, as this is a self-limited process. The course of the disease tends to worsen progressively, followed by stabilization and ultimately complete recovery, with some cases presenting with some degree of residual motor deficit. The disease course happens&#x000a0;in a period of months and lasts up to 2 years after onset.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r17">[17]</xref>&#x000a0;In some cases, although rarely described, progression to quadriparesis has been reported, with an unknown degree of recovery.<xref ref-type="bibr" rid="article-20436.r18">[18]</xref></p>
      </sec>
      <sec id="article-20436.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Paraplegia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Quadriplegia</p>
          </list-item>
          <list-item>
            <p>Depression</p>
          </list-item>
          <list-item>
            <p>Anxiety</p>
          </list-item>
          <list-item>
            <p>Unnecessary spinal surgery<xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r17">[17]</xref><xref ref-type="bibr" rid="article-20436.r18">[18]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20436.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Education is important in patients presenting with this disease, regarding awareness of the possibility of progression to significant&#x000a0;motor weakness (i.e., paraplegia/quadriplegia) and accompanied by unremitting pain in atypical&#x000a0;cases from the most severe side of the spectrum. Patients should be encouraged, and reassurance provided, as&#x000a0;this is a limited disease process, with an expectation of complete or partial self-resolution.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r1">[1]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20436.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>In severe cases, where patients have an atypical or severe&#x000a0;presentation of the disease, they may benefit from a neurologist evaluation.&#x000a0;Radiologists and pathologists may&#x000a0;assist&#x000a0;in diagnosing, as imaging and ultimately nerve biopsies may help clarify&#x000a0;ambiguous presentations or&#x000a0;rule-out other potential etiologies.&#x000a0;In conjunction with these specialists, primary care physicians, endocrinologists, psychologists, psychiatrists, social workers, neuromuscular/physiatry specialists may&#x000a0;aid in recognition, recovery, physical therapy/rehabilitation, tight glycemic&#x000a0;management, orthotic device procurement, and patient education, to ultimately provide an interprofessional approach to improve patient&#x000a0;outcomes.<xref ref-type="bibr" rid="article-20436.r1">[1]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r4">[4]</xref><xref ref-type="bibr" rid="article-20436.r3">[3]</xref><xref ref-type="bibr" rid="article-20436.r6">[6]</xref>&#x000a0;[Level&#x000a0;3]</p>
      </sec>
      <sec id="article-20436.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20436&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20436">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/diabetes/diabetic-amyotrophy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20436">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20436/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20436">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20436.s16">
        <title>References</title>
        <ref id="article-20436.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Windebank</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment.</article-title>
            <source>Muscle Nerve</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>477</fpage>
            <page-range>477-91</page-range>
            <pub-id pub-id-type="pmid">11932965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Thaisetthawatkul</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Lumbosacral plexopathy.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>5 Peripheral Nervous System Disorders</issue>
            <fpage>1343</fpage>
            <page-range>1343-58</page-range>
            <pub-id pub-id-type="pmid">25299286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massie</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mauermann</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Staff</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Amrami</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Mandrekar</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies.</article-title>
            <source>Brain</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>135</volume>
            <issue>Pt 10</issue>
            <fpage>3074</fpage>
            <page-range>3074-88</page-range>
            <pub-id pub-id-type="pmid">23065793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Llewelyn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Llewelyn</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Diabetic amyotrophy: a painful radiculoplexus neuropathy.</article-title>
            <source>Pract Neurol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-167</page-range>
            <pub-id pub-id-type="pmid">30530723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GARLAND</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Diabetic amyotrophy.</article-title>
            <source>Br Med J</source>
            <year>1955</year>
            <month>Nov</month>
            <day>26</day>
            <volume>2</volume>
            <issue>4951</issue>
            <fpage>1287</fpage>
            <page-range>1287-90</page-range>
            <pub-id pub-id-type="pmid">13269852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ng</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Laughlin</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Thapa</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Dyck</surname>
                <given-names>PJB</given-names>
              </name>
            </person-group>
            <article-title>Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus.</article-title>
            <source>Neurology</source>
            <year>2019</year>
            <month>Mar</month>
            <day>12</day>
            <volume>92</volume>
            <issue>11</issue>
            <fpage>e1188</fpage>
            <page-range>e1188-e1194</page-range>
            <pub-id pub-id-type="pmid">30760636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barrett</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Khamaisi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>BEK</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Craft</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Bowden</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Vinik</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Casellini</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2017</year>
            <month>Dec</month>
            <day>01</day>
            <volume>102</volume>
            <issue>12</issue>
            <fpage>4343</fpage>
            <page-range>4343-4410</page-range>
            <pub-id pub-id-type="pmid">29126250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tracy</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of diabetic neuropathies.</article-title>
            <source>Phys Med Rehabil Clin N Am</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-26, v</page-range>
            <pub-id pub-id-type="pmid">18194747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boulton</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Vinik</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Arezzo</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bril</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Maser</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Sosenko</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ziegler</surname>
                <given-names>D</given-names>
              </name>
              <collab>American Diabetes Association</collab>
            </person-group>
            <article-title>Diabetic neuropathies: a statement by the American Diabetes Association.</article-title>
            <source>Diabetes Care</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>956</fpage>
            <page-range>956-62</page-range>
            <pub-id pub-id-type="pmid">15793206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Norell</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy.</article-title>
            <source>Neurology</source>
            <year>1999</year>
            <month>Dec</month>
            <day>10</day>
            <volume>53</volume>
            <issue>9</issue>
            <fpage>2113</fpage>
            <page-range>2113-21</page-range>
            <pub-id pub-id-type="pmid">10599791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tracy</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Engelstad</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Microvasculitis in diabetic lumbosacral radiculoplexus neuropathy.</article-title>
            <source>J Clin Neuromuscul Dis</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-8</page-range>
            <pub-id pub-id-type="pmid">19730021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasnoor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dimachkie</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Barohn</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Diabetic neuropathy part 2: proximal and asymmetric phenotypes.</article-title>
            <source>Neurol Clin</source>
            <year>2013</year>
            <month>May</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>447</fpage>
            <page-range>447-62</page-range>
            <pub-id pub-id-type="pmid">23642718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maceyka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spiegel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Sphingolipid metabolites in inflammatory disease.</article-title>
            <source>Nature</source>
            <year>2014</year>
            <month>Jun</month>
            <day>05</day>
            <volume>510</volume>
            <issue>7503</issue>
            <fpage>58</fpage>
            <page-range>58-67</page-range>
            <pub-id pub-id-type="pmid">24899305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Albers</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Arezzo</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Biessels</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Bril</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Litchy</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>JW</given-names>
              </name>
              <collab>Toronto Expert Panel on Diabetic Neuropathy</collab>
            </person-group>
            <article-title>Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity.</article-title>
            <source>Diabetes Metab Res Rev</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>7</issue>
            <fpage>620</fpage>
            <page-range>620-8</page-range>
            <pub-id pub-id-type="pmid">21695763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kilfoyle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kelkar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Parry</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Pulsed methylprednisolone is a safe and effective treatment for diabetic amyotrophy.</article-title>
            <source>J Clin Neuromuscul Dis</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>168</fpage>
            <page-range>168-70</page-range>
            <pub-id pub-id-type="pmid">19078710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pascoe</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Windebank</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Litchy</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Subacute diabetic proximal neuropathy.</article-title>
            <source>Mayo Clin Proc</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>72</volume>
            <issue>12</issue>
            <fpage>1123</fpage>
            <page-range>1123-32</page-range>
            <pub-id pub-id-type="pmid">9413291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Dunne</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Diabetic amyotrophy progressing to severe quadriparesis.</article-title>
            <source>Muscle Nerve</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>505</fpage>
            <page-range>505-9</page-range>
            <pub-id pub-id-type="pmid">15372438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20436.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCormack</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Alam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erickson</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Cherrick</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Use of MRI in diabetic lumbosacral radiculoplexus neuropathy: case report and review of the literature.</article-title>
            <source>Acta Neurochir (Wien)</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>160</volume>
            <issue>11</issue>
            <fpage>2225</fpage>
            <page-range>2225-2227</page-range>
            <pub-id pub-id-type="pmid">30203363</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
